Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Dermatologic 1CNS 1

Conditions

Melanoma 9Skin Neoplasms 2Oligodendroglioma 1Gliosarcoma 1Glioma, Subependymal 1Glioma 1Glioblastoma 1Ependymoma 1Brain Neoplasms 1Astrocytoma 1

Interventions

pembrolizumab 4Drug Therapy 3Temozolomide 2Radiation 2Paclitaxel 2Nivolumab 2Cisplatin 2Bevacizumab 2vocimagene amiretrorepvec 1ulixertinib 1temsirolimus 1selinexor 1rovalpituzumab tesirine 1regorafenib 1pazopanib 1niraparib 1imetelstat 1fludarabine 1erythromycin propionate-N-acetylcysteinate 1epacadostat 1efineptakin alfa 1durvalumab 1dostarlimab 1cobimetinib 1cediranib 1cc-486 1carboxyamido-triazole 1bemcentinib 1aflibercept 1WP1066 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Glioblastoma × Vinblastine × Dermatologic × Clear all
NCT00498979 2020-07-24

Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other Cancers

Case Comprehensive Cancer Center

Phase 1 Completed
22 enrolled
CNSDermatologicSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Melanoma, Oligodendroglioma, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡